Surgical augmented intelligence developer Cydar Medical has entered into an exclusive agreement with global healthtech giant Philips. Pertaining to the EU, the U.K., and the U.S., the arrangement will see Philips offering Cydar EV Maps alongside its own image-guided therapy mobile C-arm system, known as Zenition. The partnership aims to empower surgical professionals with its collective technological prowess by streamlining patient-specific real-time procedure planning and guidance.
The initial offering from Cydar's platform, the FDA-cleared and CE-marked Cydar EV Maps, enhances mobile surgery-related care with cloud, AI, and computer vision. Surgeons are able to construct meticulous, patient-specific 3D maps for surgery planning. Live image guidance is then automatically augmented through said maps, which routinely update in order to help surgeons adapt to real-time events during procedures. If blood vessel navigation is hindered, or instruments deform the vessels, clinicians can rely on imaging to keep the map current with changes.
Paul Mussenden, CEO of Cydar, said, “By partnering with Philips to bring our Cydar EV Map solution to Philips’ user-friendly Zenition platform of mobile C-arms, we are a step closer to achieving our mission to ensure every image-guided minimally-invasive surgical procedure goes exactly as planned. The benefits of this combined solution, with integrated and enhanced procedure planning and visualization, include shorter and more predictable procedure times, reduced X-ray exposure to patients and staff, and fewer injections of the iodine dye—the leading cause of in-hospital kidney failure.” Cydar's cloud-based software will be used in all endovascular procedures performed with the assistance of the Zenition C-arm setup.
